4 results match your criteria: "Iran. tehraninejad@royaninstitute.org[Affiliation]"
Comparison of cabergoline and intravenous albumin in the prevention of ovarian hyperstimulation syndrome: a randomized clinical trial.
J Assist Reprod Genet
March 2012
Department of Endocrinology and Female Infertility, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, ACECR, Number 12, East Hafez Avenue, Bani Hashem Street, Resalat Highway, Tehran, Iran.
Purpose: To compare the efficacy of cabergoline (Cb2) and intravenous human albumin (HA) in the prevention of ovarian hyperstimulation syndrome.
Methods: In this randomized controlled trial study, 138 women who were at high risk for developing OHSS were randomly allocated into two groups. In Group one, 20 gr of HA 20% was infused over 1 h.
Comparison of in vitro fertilisation success in patients with polycystic ovary syndrome and tubal factor.
Gynecol Endocrinol
February 2011
Endocrinology and Female Infertility Department, Reproductive Medicine Research Centre, Royan Institute, ACECR, Tehran, Iran.
Purpose: This study is designed to compare the results of in vitro fertilisation (IVF) in polycystic ovary syndrome (PCOS) and tubal factor disorders.
Materials And Methods: This was a cohort study performed in Royan Institute from 2007 to 2009. For this evaluation, 183 patients with PCOS and 183 patients with tubal factor (control group), whose ages ranged from 22 to 35 years underwent the long protocol of pituitary suppression and were included in the study.
Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial.
J Assist Reprod Genet
May 2008
Vali-e-Asr Reproductive Health Research Center, Imam Khomeini Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Objective: To study the efficacy of the aromatase inhibitor letrozole in controlled ovarian hyperstimulation (COH).
Material And Methods: In this prospective simply randomized clinical trial, one hundred forty patients with unexplained infertility undergoing intrauterine insemination (IUI) therapy were randomized to receive either letrozole or clomiphene citrate (CC)-gonadotropin. The patients were selected among patients referred to one university hospital and one private infertility clinic.
The role of inhibin B in prediction of in vitro fertilization or intracytoplasmic sperm injection cycles' outcome.
Saudi Med J
July 2007
Department of Endocrinology and Female Infertility, Royan Institute, Simin Alley, PO Box 19395-4644, Assef Cross, Zaferanieh, Tehran, Iran.
Objective: To investigate the usefulness of inhibin B concentrations obtained on the fifth day in predicting ovarian response and assisted reproductive technologies outcome.
Methods: In this prospective multi-center study, infertile women who were candidate for in vitro fertilization or intracytoplasmic sperm injection for the first time were enrolled. These patients were referred to the Royan Institute, Vali-Asr Hospital and Alvand Hospital, Tehran, Iran between 2003 and 2004.